About Takeda Oncology

Takeda Global Oncology Leadership Team

Comprised of Takeda's global oncology commercial operations, Takeda Oncology operates in close alignment with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit (OTAU), to address unmet patient needs, move the company's products forward, and to maintain a focus on expanding our oncology pipeline. 

Takeda Oncology leadership team is comprised of the following functions and led by the following individuals: 

Teresa Bitetti

President

Global Oncology Business Unit

Christopher Arendt, Ph.D.

Head, Oncology Cell Therapy

and Therapeutic Area Unit

Samer Ansari

Head, Digital & IT,
Global Oncology Business Unit

Ana Cardoso

Head, Human Resources
Global Oncology Business Unit

Julie Dixon, Ph.D.

Head, Global Regulatory Affairs
Oncology Business Unit

Awny Farajallah, M.D.

Head, Global Medical Affairs Oncology

Carrie Fernandez

Head, Communications
Global Oncology Business Unit

Stefanie Granado, Ph.D.

Head, EUCAN Oncology Business Unit

Takafumi Horii

Head, Japan Oncology Business Unit

Heather Huet, Ph.D.

Head, Oncology Strategic Operations
Oncology Business Unit

Tetsu Inada

Chief Financial Officer
Global Oncology Business Unit

Liz Lewis

Head, Global Oncology Patient Value,
Policy and Access, Oncology Business Unit

Cristin McArdle

Head Counsel,

Global Oncology Business Unit

Ana Paula Neves

Head, E&C, Global Oncology Business Unit

Rosa Notaroberto

Head, Business Operations,

Global Oncology Business Unit

Sophie Opdyke

Head, Global Commercial Oncology,
Oncology Business Unit

Dion Warren

Head, US Oncology Business Unit